Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate
Harbour BioMed, a biotech firm with global ambitions, has just announced some seriously promising preclinical data for LET003, its first AI-enabled drug candidate. This cutting-edge…